J&J gets A HUGE Break
Once again the government has given a MAJOR corp. a MAJOR tax break. This time it is Johnson and Johnson. According to Allan Sloan of Newsweek, "J&J's tax savings on the deal will offset at least a quarter of the $16.6 billion cost, possibly much more. That's because the deal is set up as an asset purchase, and J&J is paying with cash. That makes the purchase price tax-deductible to J&J. The deal is taxable to Pfizer—but as we'll see, J&J's tax savings exceed Pfizer's tax costs."
I encourage you to read the full article Here.
I encourage you to read the full article Here.
